Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 13/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | PREP | P48147 | 2/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.52 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7359927 | 1.00 | ACE (0.67) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL7333471 | 0.92 | FKBP1A (0.60) | ACELMNASMN1; SMN2PREP | |
| SCHEMBL6418176 | 0.88 | ACE (0.87) | ACELMNASMN1; SMN2 | |
| SCHEMBL7321931 | 0.88 | ACE (0.87) | ACELMNASMN1; SMN2 | |
| SCHEMBL7327110 | 0.88 | ACE (0.74) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL7871516 | 0.87 | PREP (0.72) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL22209468 | 0.87 | PREP (0.72) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL7334484 | 0.87 | PREP (0.72) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL7322610 | 0.86 | ACE (0.60) | ACELMNASMN1; SMN2PREPACE2 | |
| SCHEMBL10866035 | 0.84 | ACE (0.48) | ACELMNASMN1; SMN2PREP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4472380-A | CARBOXYALKYL DIPEPTIDE DERIVATIVES | MERCK & CO., INC. (US) | 1984-09-18 | — | — | US | disclosed |
| US-4374829-A | Aminoacid derivatives as antihypertensives | MERCK & CO., INC. (US) | 1983-02-22 | — | — | US | disclosed |